Randomised Comparison of a Novel Buprenorphine Oral Lyophilisate versus Existing Buprenorphine Sublingual Tablets in Opioid-Dependent Patients: A First-in-Patient Phase II Randomised Open Label Safety Study-Reference-Cited by-同舟云学术

Randomised Comparison of a Novel Buprenorphine Oral Lyophilisate versus Existing Buprenorphine Sublingual Tablets in Opioid-Dependent Patients: A First-in-Patient Phase II Randomised Open Label Safety Study

Published:2017 Issue:2 Volume:23 Page:61-70
ISSN:1022-6877
Container-title:European Addiction Research
language:en
Short-container-title:Eur Addict Res

Author:

Strang John,Reed Kylie,Bogdanowicz Karolina,Bell James,van der Waal Rob,Keen Jenny,Beavan Pete,Baillie Shelagh,Knight Alastair

Publisher

S. Karger AG

Subject

Psychiatry and Mental health,Health(social science),Medicine (miscellaneous)

Reference26 articles.

1. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

2. Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial

3. Six-Year Mortality Rates of Patients in Methadone and Buprenorphine Maintenance Therapy

4. Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients

5. 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Prescribed Substance Use during the First Month of Treatment by People Receiving Depot Buprenorphine for Opioid Use Disorder;Substance Use & Misuse;2023-08-12

2. Predicting Patient Satisfaction With Medications for Treating Opioid Use Disorder: Case Study Applying Natural Language Processing to Reviews of Methadone and Buprenorphine/Naloxone on Health-Related Social Media;JMIR Infodemiology;2023-01-23

3. Undetected Respiratory Depression in People with Opioid Use Disorder;Drug and Alcohol Dependence;2022-05

4. Medication-Assisted Treatment (MAT) 1: Opioid Substitution Therapy;Opioids;2022

5. Perception of a New Prolonged-Release Buprenorphine Formulation in Patients with Opioid Use Disorder: The PREDEPO Study;European Addiction Research;2021-11-01